David Milewski

1.1k total citations
20 papers, 548 citations indexed

About

David Milewski is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, David Milewski has authored 20 papers receiving a total of 548 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 8 papers in Pulmonary and Respiratory Medicine and 7 papers in Oncology. Recurrent topics in David Milewski's work include FOXO transcription factor regulation (8 papers), CAR-T cell therapy research (5 papers) and Sarcoma Diagnosis and Treatment (4 papers). David Milewski is often cited by papers focused on FOXO transcription factor regulation (8 papers), CAR-T cell therapy research (5 papers) and Sarcoma Diagnosis and Treatment (4 papers). David Milewski collaborates with scholars based in United States, United Kingdom and Australia. David Milewski's co-authors include Tanya V. Kalin, Vladimir V. Kalinichenko, Tien Le, Xiaomeng Ren, Vladimir Ustiyan, Yan Xu, Samriddhi Shukla, David Balli, Sara Szabo and Brian Turpin and has published in prestigious journals such as Nature Communications, PLoS ONE and Cancer Research.

In The Last Decade

David Milewski

20 papers receiving 543 citations

Peers

Countries citing papers authored by David Milewski

Since Specialization

Citations

This map shows the geographic impact of David Milewski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Milewski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Milewski more than expected).

Fields of papers citing papers by David Milewski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Milewski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Milewski. The network helps show where David Milewski may publish in the future.

Co-authorship network of co-authors of David Milewski

This figure shows the co-authorship network connecting the top 25 collaborators of David Milewski. A scholar is included among the top collaborators of David Milewski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Milewski. David Milewski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Alpha4 Na,K-ATPase Localization and Expression Are Dynamic Aspects of Spermatogenesis and in Sperm Incubated Under Capacitating Conditions 2025 ·International Journal of Molecular Sciences ·David Milewski, Paul F. James	1
2	CAR T-cells targeting FGFR4 and CD276 simultaneously show potent antitumor effect against childhood rhabdomyosarcoma 2024 ·Nature Communications ·Meijie Tian, Jun S. Wei, Adam Cheuk, David Milewski, (unknown), Yong Kim, Hsien-Chao Chou, Can Liu, (unknown), (unknown), (unknown), (unknown), Michael C. Kelly, Xinyu Wen, Javed Khan	10
3	Lung endothelial cells regulate pulmonary fibrosis through FOXF1/R-Ras signaling 2023 ·Nature Communications ·(unknown), Ying‐Wei Lan, Shuyang Zhao, Zicheng Deng, Samriddhi Shukla, (unknown), (unknown), Tien Le, David Milewski, Matthew Bacchetta, Ahmed E. Hozain, Yuliya Tipograf, Ya‐Wen Chen, Yan Xu, Donglu Shi, Vladimir V. Kalinichenko, Tanya V. Kalin	55
4	Abstract 3538: Endogenous HiBiT-tagging of PAX3-FOXO1 identifies potent suppressors of PAX3-FOXO1 protein levels by high-throughput screening 2023 ·Cancer Research ·Yong Kim, Robert G. Hawley, (unknown), Teresa S. Hawley, Christine N. Evans, Raj Chari, David Milewski, (unknown), Young Song, Hsien-Chao Chou, Xinyu Wen, Ying Pang, Jing Wu, Craig J. Thomas, (unknown), Michele Ceribelli, Javed Khan	1
5	Abstract 1784: FGFR4 and CD276 dual targeting CAR T cells demonstrate synergistic antitumor activity in childhood rhabdomyosarcoma 2023 ·Cancer Research ·Meijie Tian, (unknown), Adam Cheuk, David Milewski, (unknown), (unknown), Can Liu, (unknown), Michael C. Kelly, (unknown), (unknown), Hsien-Chao Chou, Xinyu Wen, Javed Khan	1
6	Abstract 6736: Suppression of antigen presentation is a hallmark of pediatric rhabdomyosarcoma 2023 ·Cancer Research ·David Milewski, Meijie Tian, Yong Kim, (unknown), Javed Khan	1
7	Targeting EYA3 in Ewing Sarcoma Retards Tumor Growth and Angiogenesis 2021 ·Molecular Cancer Therapeutics ·Yuhua Wang, Ram Naresh Pandey, (unknown), David Milewski, Tanya V. Kalin, Sara Szabo, Joseph G. Pressey, Rashmi S. Hegde	13
8	FOXF1 is required for the oncogenic properties of PAX3-FOXO1 in rhabdomyosarcoma 2021 ·Oncogene ·David Milewski, Samriddhi Shukla, Berkley E. Gryder, Arun Pradhan, (unknown), Parvathi Sudha, (unknown), (unknown), Yan Xu, Artem Barski, Sara Szabo, Brian Turpin, Joseph G. Pressey, Douglas P. Millay, Javed Khan, Vladimir V. Kalinichenko, Tanya V. Kalin	22
9	Proteogenomic Analysis Unveils the HLA Class I-Presented Immunopeptidome in Melanoma and EGFR-Mutant Lung Adenocarcinoma 2021 ·Molecular & Cellular Proteomics ·Yue Qi, Tapan K. Maity, Constance M. Cultraro, Vikram Misra, Xu Zhang, Catherine M. Ade, Shaojian Gao, David Milewski, (unknown), (unknown), Ken‐ichi Hanada, Javed Khan, S. Cenk Şahinalp, James C. Yang, Udayan Guha	19
10	Exploring and Targeting the Tumor Immune Microenvironment of Neuroblastoma 2021 ·PubMed ·Katherine E. Masih, Jun Wei, David Milewski, (unknown)	9
11	Loss of FOXM1 in macrophages promotes pulmonary fibrosis by activating p38 MAPK signaling pathway 2020 ·PLoS Genetics ·(unknown), David Balli, (unknown), David Milewski, Tien Le, Vladimir Ustiyan, Xiaomeng Ren, Vladimir V. Kalinichenko, Tanya V. Kalin	48
12	FOXM1 nuclear transcription factor translocates into mitochondria and inhibits oxidative phosphorylation 2020 ·Molecular Biology of the Cell ·(unknown), Paritha Arumugam, Samriddhi Shukla, Arun Pradhan, Vladimir Ustiyan, David Milewski, Vladimir V. Kalinichenko, Tanya V. Kalin	30
13	IODVA1, a guanidinobenzimidazole derivative, targets Rac activity and Ras-driven cancer models 2020 ·PLoS ONE ·(unknown), (unknown), (unknown), Jacek Biesiada, Shailaja Hegde, David Milewski, Gang Ma, Tanya V. Kalin, Edward J. Merino, Jarek Meller, William Seibel, José A. Cancelas, Lisa M. Privette Vinnedge, Nicolas Nassar	7
14	The FOXM1 Inhibitor RCM-1 Decreases Carcinogenesis and Nuclear β-Catenin 2019 ·Molecular Cancer Therapeutics ·Samriddhi Shukla, David Milewski, Arun Pradhan, (unknown), Kathryn Rice, Tien Le, Matthew J. Flick, Sara Vaz, Xueheng Zhao, Kenneth D.R. Setchell, Elsa Logarinho, Vladimir V. Kalinichenko, Tanya V. Kalin	44
15	Improved Tumor Control Through T-cell Infiltration Modulated by Ultra-High Dose Rate Proton FLASH Using a Clinical Pencil Beam Scanning Proton System 2019 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), Tamoghna Saha, (unknown), (unknown), David Milewski, Anthony Mascia, Ralph E. Vatner, Dilip K. Sengupta, (unknown), E. Paige Abel, Swati Girdhani, Mitsue Miyazaki, (unknown), Andrew Ku, Rajiv Dua, Renate Parry, Tanya V. Kalin	49
16	The FOXM1 Inhibitor RCM‐1 Decreases Carcinogenesis and Nuclear β‐catenin 2019 ·The FASEB Journal ·(unknown), Samriddhi Shukla, David Milewski, Tanya V. Kalin	1
17	Targeted Inhibition of the Dual Specificity Phosphatases DUSP1 and DUSP6 Suppress MPNST Growth via JNK 2019 ·Clinical Cancer Research ·Annmarie Ramkissoon, (unknown), David Milewski, Kyle Williams, (unknown), Kwangmin Choi, (unknown), Tanya V. Kalin, Joseph G. Pressey, Sara Szabo, Mohammad Azam, David A. Largaespada, Nancy Ratner	60
18	FOXF1 Inhibits Pulmonary Fibrosis by Preventing CDH2-CDH11 Cadherin Switch in Myofibroblasts 2018 ·Cell Reports ·(unknown), David Milewski, Tien Le, Xiaomeng Ren, Yan Xu, Vladimir V. Kalinichenko, Tanya V. Kalin	69
19	FOXM1 activates AGR2 and causes progression of lung adenomas into invasive mucinous adenocarcinomas 2017 ·PLoS Genetics ·David Milewski, David Balli, Vladimir Ustiyan, Tien Le, Hendrik Dienemann, Arne Warth, Kai Breuhahn, Jeffrey A. Whitsett, Vladimir V. Kalinichenko, Tanya V. Kalin	53
20	FoxF1 and FoxF2 transcription factors synergistically promote rhabdomyosarcoma carcinogenesis by repressing transcription of p21Cip1 CDK inhibitor 2016 ·Oncogene ·David Milewski, Aliza Pradhan, Xiaolin Wang, Yuqi Cai, Tien Le, Brian Turpin, Vladimir V. Kalinichenko, (unknown)	55

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact